C07H 19/048
Pyridine radicals
C07H19/048 (Pyridine radicals) appears on 176 US grants and 241 published applications in this corpus.
Search patents in C07H- Granted patents
- 176
- Published applications
- 241
- Assignees
- 125
- Inventors
- 349
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 4 |
| 2004 | 0 | 5 |
| 2005 | 4 | 6 |
| 2006 | 4 | 13 |
| 2007 | 5 | 16 |
| 2008 | 5 | 4 |
| 2009 | 6 | 4 |
| 2010 | 3 | 4 |
| 2011 | 7 | 6 |
| 2012 | 4 | 7 |
| 2013 | 4 | 6 |
| 2014 | 6 | 8 |
| 2015 | 3 | 3 |
| 2016 | 3 | 11 |
| 2017 | 4 | 11 |
| 2018 | 7 | 20 |
| 2019 | 16 | 14 |
| 2020 | 11 | 11 |
| 2021 | 14 | 18 |
| 2022 | 13 | 15 |
| 2023 | 8 | 17 |
| 2024 | 11 | 17 |
| 2025 | 10 | 13 |
| 2026 | 5 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 3′ protected nucleotides6 Oct 2026US 12,753,201 B2Roche Sequencing Solutions, Inc.
- Polymorphic form of reduced B-nicotinamide mononucleotide calcium salt, and preparation method and use therefor28 Jul 2026US 12,692,287 B2Effepharm (Shanghai) Co., Ltd.
- Method for increasing bulk density of nicotinamide mononucleotide crystal and crystal thereof10 Mar 2026US 12,570,682 B2Bontac Bio-Engineering (Shenzhen) Co., Ltd
- Polymorphic form of reduced beta-nicotinamide mononucleotide disodium salt, and preparation method therefor and use thereof10 Mar 2026US 12,570,683 B2Effepharm (Shanghai) Co., Ltd.
- Anti-viral compounds and methods of use6 Jan 2026US 12,516,081 B2Metro International Biotech, LLC
- Polymorphic form of reduced ß-nicotinamide mononucleotide calcium salt, and preparation method and use therefor1 Oct 2026US 2026/0297122 A1Effepharm (Shanghai) Co., Ltd.
- Inorganic salts of nicotinic acid mononucleotide as anti-aging agents13 Aug 2026US 2026/0234179 A1Jumpstart Fertility Pty Ltd
- Polymorphic form of reduced beta-nicotinamide mononucleotide disodium salt, and preparation method therefor and use thereof25 Jun 2026US 2026/0176297 A1Effepharm (Shanghai) Co., Ltd.
- Crystalline complex, method for producing thereof, and composition28 May 2026US 2026/0144282 A1Kaneka Corporation
- Methods of preparing reduced nicotinamide riboside and derivatives thereof5 Mar 2026US 2026/0062436 A1The Queen's University of Belfast
Most cited
By later US patents
- Synthesis of locked nucleic acid derivatives199US 7,569,575 B2Santaris Pharma A/S · 2009
- Modified fluorinated nucleoside analogues157US 7,429,572 B2Pharmasset, Inc. · 2008
- Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections149US 7,608,600 B2Centre National De La Recherche Scientifique · 2009
- Nucleoside analogs and oligonucleotide derivatives containing these analogs133US 7,053,199 B22006
- Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infections100US 7,365,057 B2Centre National De La Recherche Scientifique · 2008